The Heart Institute, University of São Paulo is one of the clinical institutes of the central University's teaching hospital and recognized as one of the world's academic and clinical excellence centers in cardiology, cardiovascular medicine and cardiovascular surgery.

During the past decade, Heart Institute (InCor) conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Institute (InCor)" #1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 7 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 7 trials as a collaborator, "Feculdade de Medicina da Universidade de Sao Paulo - Brasil" with 1 trials as a collaborator, "Federal University of Paraíba" with 1 trials as a collaborator and "Hospital Santa Marcelina" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Heart Institute (InCor)" are "Obstructive Sleep Apnea" (6 trials), "Coronary Artery Disease" (4 trials), "Atherosclerosis" (3 trials), "Inflammation" (3 trials) and "Acute Renal Failure" (2 trials). Many other conditions were trialed in "Heart Institute (InCor)" in a lesser frequency.

Most popular intervention types in "Heart Institute (InCor)" are "Device" (8 trials), "Drug" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "CPAP" (4 trials), "IVUS-guided PCI" (2 trials), "0,9% Saline" (1 trials), "Aerobic Exercise Training" (1 trials) and "Angiography-guided PCI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Institute (InCor)" are 17 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Heart Institute (InCor)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Heart Institute (InCor), 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Institute (InCor), 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".